Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients. (Record no. 28794349)

MARC details
000 -LEADER
fixed length control field 02129 a2200613 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517234704.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201910s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1534-6277
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s11864-018-0565-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kumar, Abhijeet
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20191003
245 00 - TITLE STATEMENT
Title Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current treatment options in oncology
Date of publication, distribution, etc. 09 2018
300 ## - PHYSICAL DESCRIPTION
Extent 50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anthracyclines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brentuximab Vedotin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Frail Elderly
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoconjugates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lenalidomide
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Large B-Cell, Diffuse
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prednisone
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vincristine
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fraz, Muhammad Asad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Usman, Muhammad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Malik, Saad Ullah
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ijaz, Awais
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Durer, Ceren
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Durer, Seren
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tariq, Muhammad Junaid
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Khan, Ali Younas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qureshi, Anum
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Faridi, Warda
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nasar, Aboo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anwer, Faiz
773 0# - HOST ITEM ENTRY
Title Current treatment options in oncology
Related parts vol. 19
-- no. 10
-- p. 50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s11864-018-0565-6">https://doi.org/10.1007/s11864-018-0565-6</a>
Public note Available from publisher's website

No items available.